Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Christopher Sarchi

Chief Commercial Officer at Replimune Group, Inc. (REPL)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $254K

Reported trades

Filed Stock Type Shares Price Value Since
Jun 3SEC REPLReplimune Group, Inc. Sell Plan 12,000180,962 held (−6%) $9.24 $111K +17.5%
May 20SEC REPLReplimune Group, Inc. Sell 8,626192,962 held (−4%) $5.08 $44K +113.8%
Apr 6SEC REPLReplimune Group, Inc. Sell Plan 6,500151,588 held (−4%) $8.01 $52K +35.6%
Nov 19SEC REPLReplimune Group, Inc. Sell 5,208123,088 held (−4%) $9.10 $47K +19.3%
  • Sell

    Chief Commercial Officer Christopher Sarchi sold $111K of REPL at $9.24 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Commercial Officer Christopher Sarchi sold $52K of REPL at $8.01 — pre-scheduled 10b5-1 plan sale.